MIRA Pharmaceuticals, Inc. (MIRA) Financial Statements
MIRA Pharmaceuticals, Inc. Financial Overview
MIRA Pharmaceuticals, Inc.'s market cap is currently $23.05M. The company's EPS TTM is $-1.38; its P/E ratio is -0.40; MIRA Pharmaceuticals, Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -10.49M | $ -8.02M | $ -8.53M | $ -7.05M | $ -2.15M |
| EBITDA | $ -10.44M | $ -8.02M | $ -8.53M | $ 0.00 | $ 0.00 |
| Net Income | $ -10.44M | $ -7.85M | $ -11.98M | $ -7.06M | $ -2.18M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 6.35M | $ 2.83M | $ 4.60M | $ 350.98K | $ 2.81M |
| Total Assets | $ 11.09M | $ 2.92M | $ 4.93M | $ 858.07K | $ 3.36M |
| Total Debt | $ 0.00 | $ 0.00 | $ 5.06K | $ 491.23K | $ 293.06K |
| Net Debt | $ -6.35M | $ -2.83M | $ -4.60M | $ 140.25K | $ -2.52M |
| Total Liabilities | $ 702.07K | $ 723.35K | $ 558.10K | $ 1.45M | $ 1.09M |
| Stockholders' Equity | $ 10.39M | $ 2.20M | $ 4.37M | $ -596.23K | $ 2.26M |
| Cash Flow | |||||
| Free Cash Flow | $ -4.66M | $ -5.56M | $ -4.53M | $ -5.60M | $ -1.38M |
| Operating Cash Flow | $ -4.66M | $ -5.56M | $ -4.53M | $ -5.60M | $ -1.38M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 8.18M | $ 3.79M | $ 8.78M | $ 3.15M | $ 4.18M |
Currency in USD